Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Mycenax Biotech Inc. (4726) Financial Statements

Mycenax Biotech Inc. Financial Overview

Mycenax Biotech Inc.'s market cap is currently NT$4.76B. The company's EPS TTM is NT$-1.85; its P/E ratio is -12.16; Mycenax Biotech Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 740.24MNT$ 683.92MNT$ 652.62MNT$ 732.28MNT$ 774.27M
Gross ProfitNT$ -181.41MNT$ -241.36MNT$ -375.19MNT$ -113.67MNT$ 137.61M
Operating IncomeNT$ -403.84MNT$ -461.48MNT$ -602.10MNT$ -412.49MNT$ -92.14M
EBITDANT$ -119.51MNT$ -136.46MNT$ -339.48MNT$ -160.34MNT$ 82.83M
Net IncomeNT$ -448.63MNT$ -467.13MNT$ -682.85MNT$ -453.63MNT$ -89.86M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 225.75MNT$ 278.06MNT$ 668.89MNT$ 1.34BNT$ 295.43M
Total AssetsNT$ 3.26BNT$ 3.37BNT$ 3.77BNT$ 4.45BNT$ 3.14B
Total DebtNT$ 1.07BNT$ 883.39MNT$ 726.28MNT$ 955.85MNT$ 744.64M
Net DebtNT$ 847.35MNT$ 613.83MNT$ 207.01MNT$ -367.51MNT$ 457.72M
Total LiabilitiesNT$ 1.66BNT$ 1.34BNT$ 1.32BNT$ 1.35BNT$ 1.23B
Stockholders' EquityNT$ 1.60BNT$ 2.02BNT$ 2.45BNT$ 3.11BNT$ 1.91B
Cash Flow
Free Cash FlowNT$ -126.32MNT$ -522.19MNT$ -428.78MNT$ -789.16MNT$ -1.26B
Operating Cash FlowNT$ -27.24MNT$ -191.68MNT$ -131.18MNT$ -150.19MNT$ -146.23M
Investing Cash FlowNT$ -112.44MNT$ -174.93MNT$ -443.15MNT$ -745.24MNT$ -1.03B
Financing Cash FlowNT$ 94.91MNT$ 116.58MNT$ -229.73MNT$ 1.93BNT$ 1.17B

Currency in TWD

Mycenax Biotech Inc. Earnings and Revenue History

-800M0800M1.6B-120 %-60 %0 %60 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Mycenax Biotech Inc. Liabilities to Assets

02B4B6B24 %36 %48 %60 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Mycenax Biotech Inc. Cash Flow

-2B-1B01B2B3B2019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Mycenax Biotech Inc. Forecast EPS vs Actual EPS

-0.7-0.6-0.5-0.4-0.3-0.2-0.1Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss
Earnings >